ST. LOUIS, June 22, 2017 /PRNewswire/ -- Canopy BiosciencesTM, LLC ("Canopy Biosciences"), an emerging provider of gene editing and personalized medicine technologies, announced a distributor agreement with Cosmo Bio Co., Ltd. ("Cosmo Bio") for its TUNR Flexible Gene Editing technology in Japan. Cosmo Bio is one of Japan's largest and most established reagents and services suppliers in the life science industry, and Canopy Biosciences will work with Cosmo Bio to gain direct access to customers and support projects throughout the Japanese academic and biopharmaceutical industry.
"We are dedicated to bringing our genetic engineering tools to researchers across the globe and expanding our footprint in Japan," said Edward Weinstein, PhD, President and CEO of Canopy Biosciences. "Cosmo Bio is an ideal distribution partner for our genetic engineering products and services due to their deep technical expertise and fantastic customer relationships."
"The genetic engineering market continues to grow at a rapid pace in Japan and we anticipate that the TUNR technology will become a key factor in gene editing. We are very pleased to represent Canopy Biosciences in Japan, bringing our researchers the latest genetic engineering tools," said Haruhisa Sakurai, PhD, President of Cosmo Bio.
About Canopy BiosciencesTM, LLC
Canopy Biosciences was formed in 2016, collaborating with leading research institutions to turn their discoveries into tangible products and make them available to the entire research community. Canopy Biosciences was formed with investment from BioGenerator, an evergreen investor in the St. Louis region. A complete list of products and services can be found at www.canopybiosciences.com.
Canopy Biosciences is trademarked by Canopy Biosciences, LLC.
About Cosmo Bio Co., Ltd. Cosmo Bio was formed in 1983, an organization established to sell and distribute biological reagents and services for research purposes, headquartered in Tokyo, with a network of over 200 contracted dealers throughout Japan. Cosmo Bio is one of the largest and most established life sciences reagents and services suppliers in Japan. Learn more at www.cosmobio.co.jp.
Advertisement
"We are dedicated to bringing our genetic engineering tools to researchers across the globe and expanding our footprint in Japan," said Edward Weinstein, PhD, President and CEO of Canopy Biosciences. "Cosmo Bio is an ideal distribution partner for our genetic engineering products and services due to their deep technical expertise and fantastic customer relationships."
Advertisement
"The genetic engineering market continues to grow at a rapid pace in Japan and we anticipate that the TUNR technology will become a key factor in gene editing. We are very pleased to represent Canopy Biosciences in Japan, bringing our researchers the latest genetic engineering tools," said Haruhisa Sakurai, PhD, President of Cosmo Bio.
About Canopy BiosciencesTM, LLC
Canopy Biosciences was formed in 2016, collaborating with leading research institutions to turn their discoveries into tangible products and make them available to the entire research community. Canopy Biosciences was formed with investment from BioGenerator, an evergreen investor in the St. Louis region. A complete list of products and services can be found at www.canopybiosciences.com.
Canopy Biosciences is trademarked by Canopy Biosciences, LLC.
About Cosmo Bio Co., Ltd. Cosmo Bio was formed in 1983, an organization established to sell and distribute biological reagents and services for research purposes, headquartered in Tokyo, with a network of over 200 contracted dealers throughout Japan. Cosmo Bio is one of the largest and most established life sciences reagents and services suppliers in Japan. Learn more at www.cosmobio.co.jp.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/canopy-biosciences-announces-distribution-agreement-with-cosmo-bio-for-japan-life-science-market-300474734.html
SOURCE Canopy Biosciences
